BRAF, a target in melanoma: implications for solid tumor drug development

Cancer
Keith T Flaherty, Grant A McArthur

Abstract

The successful translation of therapies targeting signal-transduction pathways that are activated by oncogenes has provided a model for molecularly targeted therapy, and the identification of mutations in v-raf murine sarcoma viral oncogene homolog B1 (BRAF), a serine/threonine kinase, has turned the attention of the melanoma field toward this concept. The current review indicated that BRAF represents an important target in cancer, in part because it is present in 7% of all cancers and also because it represents the first intracellular signaling molecule that is activated by point mutations for which single-agent therapy appears to have efficacy. Therapy for advanced melanoma has progressed slowly over the past 3 decades, although significant advances have been made in other cancers with the application of cytotoxic chemotherapy and targeted therapies. However, in melanoma, cytotoxic chemotherapies have severe limits, chemotherapy does not convincingly improve on the natural history of metastatic disease and has no role in the adjuvant setting, and cytokine therapy may have a niche in both the adjuvant and metastatic settings but confers only a modest benefit to a small proportion of patients at the cost of severe toxicity. Thu...Continue Reading

References

Jul 1, 1989·Molecular and Cellular Biology·L J van 't VeerJ L Bos
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
Mar 20, 2003·Journal of the National Cancer Institute·Gad SingerIe-Ming Shih
Apr 17, 2003·Journal of the National Cancer Institute·Yoram CohenDavid Sidransky
Jul 25, 2003·Oncogene·Anette WeberAndrea Tannapfel
Sep 13, 2003·Cancer Letters·Norihisa IshimuraYoshikazu Kinoshita
Sep 23, 2003·The American Journal of Dermatopathology·Pablo UribeSergio González
Sep 26, 2003·Oncogene·Toshihiko FukushimaSeiichi Takenoshita
Jan 8, 2004·The Journal of Investigative Dermatology·Amir S YazdiChristian A Sander
Feb 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·M Golam MohiBenjamin G Neel
Mar 11, 2004·The Journal of Investigative Dermatology·Hensin TsaoFrank G Haluska
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Apr 3, 2004·Cancer Research·Claudia WellbrockRichard Marais
Jun 10, 2004·British Journal of Cancer·S BamfordR Wooster
Jun 23, 2004·Oncogene·Maria KarasaridesRichard Marais
Oct 19, 2004·Cancer Cell·Mathew J Garnett, Richard Marais
Nov 2, 2004·Acta Neuropathologica·Christiane B KnobbeGuido Reifenberger
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Derek L DaiGang Li
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David B SolitFrank M Sirotnak
Mar 23, 2005·Cancer Research·Arati SharmaGavin P Robertson
Mar 29, 2005·The American Journal of Pathology·Robyn BeachAsif Rashid
Jun 3, 2005·Pediatric Blood & Cancer·Abdul AlsultanFrederick D Goldman
Jul 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sérgia VelhoRaquel Seruca
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia M LorussoMark B Meyer
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
Nov 8, 2005·Nature·David B SolitNeal Rosen
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Jan 19, 2006·The Journal of Investigative Dermatology·Vikas K GoelFrank G Haluska
Jan 19, 2006·The Journal of Investigative Dermatology·Pablo UribeSergio Gonzalez
May 25, 2006·International Journal of Cancer. Journal International Du Cancer·Nam-Yun ChoGyeong Hoon Kang
Jun 28, 2006·The Journal of Experimental Medicine·Hidetoshi SumimotoYutaka Kawakami
Aug 2, 2006·British Journal of Cancer·T EisenM J Ratain
Sep 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher

❮ Previous
Next ❯

Citations

Aug 19, 2011·Cancer Immunology, Immunotherapy : CII·Christian U BlankTon N Schumacher
Nov 3, 2011·Expert Reviews in Molecular Medicine·Ivan PachecoVictor Tron
May 30, 2013·The American Journal of Dermatopathology·Katherine E BrickMargot S Peters
Dec 3, 2011·Science Translational Medicine·Sameek RoychowdhuryArul M Chinnaiyan
Jun 1, 2012·Science Translational Medicine·Banibrata SenFaye M Johnson
Oct 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laszlo G RadvanyiPatrick Hwu
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul K PaikGregory J Riely
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa ZimmerDirk Schadendorf
Nov 1, 2011·PloS One·Hazem El-OstaRazelle Kurzrock
Jan 8, 2013·Clinical Pharmacology : Advances and Applications·Jung-Ki YoonKevin B Kim
Apr 17, 2014·Journal of Carcinogenesis·Anthony Jarkowski, Nikhil I Khushalani
Sep 4, 2014·Annual Review of Genomics and Human Genetics·Sameek Roychowdhury, Arul M Chinnaiyan
Aug 21, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Adilson Kleber FerreiraDurvanei Augusto Maria
Jan 25, 2013·The Journal of Investigative Dermatology·Fang LiuRutao Cui
Jul 28, 2011·International Journal of Andrology·D KoychevF Honecker
Oct 17, 2012·International Journal of Dermatology·Zendee ElabaMichael J Murphy
Oct 11, 2011·Bioscience Reports·Rolando Pérez-Lorenzo, Bin Zheng
Jun 14, 2015·Cancer Chemotherapy and Pharmacology·Letizia PorcelliAmalia Azzariti
Jun 26, 2013·The Journal of Molecular Diagnostics : JMD·John F PalmaPer Guldberg
Nov 12, 2016·Frontiers in Endocrinology·Monica MarzagalliPatrizia Limonta
Apr 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karlijn KoersJos A van der Hage
Mar 23, 2017·Current Neurology and Neuroscience Reports·Nicole ShonkaManmeet S Ahluwalia
Sep 15, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jae-Rim HeoKyung-Chul Choi
Mar 23, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Harma EllensLauren E Richards-Peterson
Apr 22, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sarah K LawrenceKonstantine W Skordos
Jan 17, 2020·Cells·Ufuk DegirmenciJiancheng Hu
Apr 19, 2017·Oncotarget·Eva HulstaertPieter Mestdagh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Keith T FlahertyPaul B Chapman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Georgina V LongRichard F Kefford
Cancer Cell
Poulikos I Poulikakos, Neal Rosen
The New England Journal of Medicine
David B Solit, Neal Rosen
© 2021 Meta ULC. All rights reserved